Skip to main content
. 2022 Aug 1;13:939057. doi: 10.3389/fimmu.2022.939057

Table 1.

Baseline characteristics of all patients.

Characteristics and laboratory parameters All patients Positive*n = 103 Negative n = 23 p-value
Age, mean (range), years 50.30 ± 16.55 52.23 ± 16.72 50.00 ± 18.55 >0.05
Sex, female, n (%) 99 (78.6) 79 (73.7) 20 (87.0) >0.05
WBC (×109/L) 8.60 ± 5.22 8.86 ± 5.21 8.23 ± 6.60 >0.05
Hb (×109/L) 112.52 ± 22.56 114.74 ± 22.66 111.38 ± 23.95 >0.05
PLT (×109/L) 228.02 ± 114.00 223.21 ± 120.93 213.31 ± 89.26 >0.05
Neutrophil (×109/L) 7.64 ± 7.57 8.10 ± 9.01 8.44 ± 7.50 >0.05
Neutrophil% 75.45 ± 16.96 75.05 ± 18.86 73.21 ± 24.09 >0.05
Lymphocyte (×109/L) 1.09 ± 0.74 1.12 ± 0.83 1.01 ± 0.93 >0.05
Lymphocyte% 15.97 ± 11.24 15.29 ± 10.53 15.27 ± 9.66 >0.05
Monocyte (×109/L) 1.35 ± 10.11 0.44 ± 0.25 0.40 ± 0.30 >0.05
Monocyte% 75.45 ± 16.97 5.80 ± 3.60 5.38 ± 2.48 >0.05
Erythrocyte sedimentation rate (mm/h) 64.47 ± 43.36 67.09 ± 42.34 53.92 ± 38.99 >0.05
C-reactive protein 53.50 ± 67.32 61.70 ± 77.87 31.82 ± 44.68 >0.05
Procalcitonin 2.08 ± 7.04 2.41 ± 7.81 0.56 ± 0.21 >0.05
Glucocorticoid use, n (%) 53 40 (38.8%) 13 (56.5%) >0.05
DMARDs use, n (%) 45 33 (32.0%) 12 (52.2%) >0.05

*The infection group included 98 mNGS positive and 5 only CDT positive. The non-infection group means negative for mNGS and CDT.